Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(3S,9S,12S,15S,18S,24S,27S,30S,33S,36S)-1-((S)-1-((S)-2-((S)-4-amino-2-((S)-4-amino-2-((2S,3R)-2-amino-3-hydroxybutanamido)-4-oxobutanamido)-4-oxobutanamido)-3-hydroxypropanoyl)pyrrolidin-2-yl)-27-(2-amino-2-oxoethyl)-12,18-dibenzyl-15,36-bis((R)-1-hydroxyethyl)-3,30,33-tris(hydroxymethyl)-9-isopropyl-24-methyl-1,4,7,10,13,16,19,22,25,28,31,34-dodecaoxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaazaheptatriacontan-37-oic acid
ID: ALA5189089
Chembl Id: CHEMBL5189089
PubChem CID: 168279036
Max Phase: Preclinical
Molecular Formula: C71H106N20O28
Molecular Weight: 1687.74
Associated Items: